ID
34057
Description
Study ID: 101998 Clinical Study ID: 101998 Study Title: A randomized, double-blind, parallel group, placebo-controlled, single-attack evaluation of the efficacy and tolerability of TREXIMA™ (sumatriptan 85mg/naproxen sodium 500mg)* tablets vs placebo when administered during the mild pain phase of a migraine Patient Level Data Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier Sponsor GlaxoSmithKline Collaborators N/A Phase Phase 3 Study Recruitment Status Completed Generic Name sumatriptan Trade Name Imitrex ,Imiject ,Imigran Study Indication Migraine Disorders This document asks if the subject is of child-bearing potential and which birth control methods the subject is using to prevent pregnancy during the study. This form should be filled out by female subjects at the screening visit.
Mots-clés
Versions (3)
- 11/01/2019 11/01/2019 -
- 13/01/2019 13/01/2019 -
- 17/01/2019 17/01/2019 -
Détendeur de droits
GlaxoSmithKline
Téléchargé le
13 janvier 2019
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Efficacy and Tolerability of TREXIMA Tablets vs. Placebo During Mild Migraine Study ID 101998
Child Bearing Potential and Birth Control
- StudyEvent: ODM
Similar models
Child Bearing Potential and Birth Control
- StudyEvent: ODM
C0086129 (UMLS CUI [1,2])
C0004764 (UMLS CUI [1,2])
C0042241 (UMLS CUI [2])
C3873750 (UMLS CUI [3])
C2348235 (UMLS CUI [1,2])